Targeted next-generation sequencing reveals CDKN2A alterations as a prognostic biomarker in recurrent or metastatic head and neck squamous cell carcinoma mostly treated with immune checkpoint inhibitors

被引：0
|
作者：
Guo, Y. [1 ]
Xue, L. [1 ]
Tang, W. [1 ]
Zhou, J. [1 ]
Xue, J. [1 ]
Li, Q. [1 ]
Ge, X. [1 ]
Lin, F. [1 ]
Zhao, W. [1 ]
机构：
[1] Tongji Univ, Shanghai East Hosp, Med Oncol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
879P
引用
收藏
页码：S565 / S566
页数：2
相关论文
共 50 条
  • [1] Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors
    Xue, Liqiong
    Tang, Wenbo
    Zhou, Jiuli
    Xue, Junli
    Li, Qun
    Ge, Xiaoxiao
    Lin, Fengjuan
    Zhao, Wei
    Guo, Ye
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
    Lim, Sun Min
    Cho, Sang Hee
    Hwang, In Gyu
    Choi, Jae Woo
    Chang, Hyun
    Ahn, Myung-Ju
    Park, Keon Uk
    Kim, Ji-Won
    Ko, Yoon Ho
    Ahn, Hee Kyung
    Cho, Byoung Chul
    Nam, Byung-Ho
    Chun, Sang Hoon
    Hong, Ji Hyung
    Kwon, Jung Hye
    Choi, Jong Gwon
    Kang, Eun Joo
    Yun, Tak
    Lee, Keun-Wook
    Kim, Joo-Hang
    Kim, Jin Soo
    Lee, Hyun Woo
    Kim, Min Kyoung
    Jung, Dongmin
    Kim, Ji Eun
    Keam, Bhumsuk
    Yun, Hwan Jung
    Kim, Sangwoo
    Kim, Hye Ryun
    CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 300 - 312
  • [3] Preserving momentum on next-generation sequencing for head and neck squamous cell carcinoma
    Rossi, A.
    Zampiva, I.
    Sperduti, I.
    Conciatori, F.
    Bazzichetto, C.
    Nocini, R.
    Milella, M.
    ANNALS OF ONCOLOGY, 2024, 35 (10) : 919 - 921
  • [4] Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors
    Arribas, Lorena
    Plana, Maria
    Taberna, Miren
    Sospedra, Maria
    Vilarino, Noelia
    Oliva, Marc
    Pallares, Natalia
    Gonzalez Tampan, Ana Regina
    Miguel Del Rio, Luis
    Mesia, Ricard
    Baracos, Vickie
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Investigating the feasibility of targeted next-generation sequencing to guide the treatment of head and neck squamous cell carcinoma.
    Keam, Bhumsuk
    Lim, Sun Min
    Cho, Sang-Hee
    Hwang, In Gyu
    Ahn, Myung-Ju
    Park, Keon Uk
    Kim, Ji-Won
    Ko, Yoon Ho
    Ahn, Hee Kyung
    Chun, Sang Hoon
    Hong, Ji Hyung
    Choi, Jonggwon
    Kang, Eun Joo
    Yun, Tak
    Lee, Keun Wook
    Kim, Jin-Soo
    Lee, Hyun Woo
    Kim, Min Kyoung
    Yun, Hwan Jung
    Kim, HyeRyun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Prognostic significance of nutritional indices in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors
    Miyamoto, Noriyuki
    Takenaka, Yukinori
    Sudo, Takato
    Eguchi, Hirotaka
    Tanaka, Hidenori
    Fukusumi, Takahito
    Takemoto, Norihiko
    Suzuki, Motoyuki
    Inohara, Hidenori
    ACTA OTO-LARYNGOLOGICA, 2023, 143 (10) : 925 - 930
  • [7] Dual Immune Checkpoint Blockade and Hypofractionated Radiation in Recurrent/Metastatic Squamous Cell Carcinomas of the Head and Neck Previously Treated with Immune Checkpoint Inhibitors
    Rodriguez, C. P.
    Fromm, J.
    Liao, J. J.
    Laramore, G. E.
    Lo, S. S.
    Goff, P. H.
    Santana-Davila, R.
    Martins, R. G.
    Futran, N.
    Houlton, J.
    Barber, B.
    Parvathaneni, U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E282 - E283
  • [8] Molecular Heterogeneity of Head and Neck Squamous Cell Carcinoma Defined by Next-Generation Sequencing
    Zhang, Pan
    Mirani, Neena
    Baisre, Ada
    Fernandes, Helen
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (05): : 1323 - 1330
  • [9] Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors
    Matthias Lechner
    Garrett M Frampton
    Tim Fenton
    Andrew Feber
    Gary Palmer
    Amrita Jay
    Nischalan Pillay
    Martin Forster
    Maureen T Cronin
    Doron Lipson
    Vincent A Miller
    Timothy A Brennan
    Stephen Henderson
    Francis Vaz
    Paul O'Flynn
    Nicholas Kalavrezos
    Roman Yelensky
    Stephan Beck
    Philip J Stephens
    Chris Boshoff
    Genome Medicine, 5
  • [10] Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV plus and HPV- tumors
    Lechner, Matthias
    Frampton, Garrett M.
    Fenton, Tim
    Feber, Andrew
    Palmer, Gary
    Jay, Amrita
    Pillay, Nischalan
    Forster, Martin
    Cronin, Maureen T.
    Lipson, Doron
    Miller, Vincent A.
    Brennan, Timothy A.
    Henderson, Stephen
    Vaz, Francis
    O'Flynn, Paul
    Kalavrezos, Nicholas
    Yelensky, Roman
    Beck, Stephan
    Stephens, Philip J.
    Boshoff, Chris
    GENOME MEDICINE, 2013, 5
12345